MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Leukemia P388

(UMLS:C0023429)

Definition:: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
UMLS ID:: C0023429
MeSH ID:: D007941

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.337.372.782|C04.619.531.782

Synonym(s)

Leukemia P388

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	azonafide		7699715	CTD
2	geraniol		1988098	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Leukemia L1210	52.5%
2	Carcinoma, Ehrlich Tumor	26.7%
3	Carcinoma, Lewis Lung	26.7%
4	Carcinoma 256, Walker	25.7%
5	Neoplasms, Germ Cell and Embryonal	23.6%
6	Neoplasms, Glandular and Epithelial	23.6%
7	Germ Cell Cancer	23.6%
8	Hamartoma	22.4%
9	Neoplasms, Hormone-Dependent	22.4%
10	Neoplasms, Multiple Primary	22.4%
11	Paraneoplastic Syndromes	22.4%
12	Precancerous Conditions	22.4%
13	Neoplasms, Second Primary	22.4%
14	Leukemia, Plasma Cell	22.2%
15	Neuroectodermal Tumors	21.5%
16	Sarcoma, Experimental	21.2%
17	Sarcoma, Myeloid	21.1%
18	Melanoma, Experimental	20.5%
19	Neoplasms, Neuroepithelial	20.3%
20	Gliomatosis cerebri	20.3%
21	Leukemia, Radiation-Induced	20.2%
22	Mammary Neoplasms, Experimental	20%
23	Carcinosarcoma	18%
24	Hemangiosarcoma	18%
25	lymphangiosarcoma	18%
26	Sarcoma 180	18%
27	Histiocytic Disorders, Malignant	17.6%
28	melanoma	17.5%
29	Cyst	16.8%
30	Neoplastic Processes	16.8%
31	Neoplastic Syndromes, Hereditary	16.8%
32	Pregnancy Complications, Neoplastic	16.8%
33	Dermoid Cyst	16.7%
34	Meningioma	16.3%
35	Trophoblastic Neoplasms	16.1%
36	Medulloblastoma	15.1%
37	Adenoma, Acidophil	14.8%
38	Ganglioneuroma	14.8%
39	Glioma	14.8%
40	Malignant Glioma	14.8%
41	Basal cell carcinoma	14.6%
42	Carcinoma, Papillary	14.6%
43	Squamous cell carcinoma	14.6%
44	Chondrosarcoma	14.6%
45	Craniopharyngioma	14.6%
46	Cystadenoma	14.6%
47	leiomyosarcoma	14.6%
48	liposarcoma	14.6%
49	Mesothelioma	14.6%
50	synovial sarcoma	14.6%
51	Neuroectodermal Tumor, Melanotic	14.6%
52	Angiomyolipoma	14.6%
53	Clear Cell Sarcoma of Soft Tissue	14.6%
54	Alveolar Soft Part Sarcoma	14.6%
55	Neuroendocrine Tumors	14.6%
56	Carcinoma, Basal Cell	14.6%
57	Adenoma	14.3%
58	Ameloblastoma	14.3%
59	Angiokeratoma	14.3%
60	Carcinoma	14.3%
61	Chordoma	14.3%
62	Hemangioma	14.3%
63	hemangiopericytoma	14.3%
64	Lymphangioma	14.3%
65	Mesenchymoma	14.3%
66	Nevus	14.3%
67	Teratoma	14.3%
68	Hepatoblastoma	14.3%
69	Mixed Tumor, Mullerian	14.3%
70	Germinoma	14.3%
71	Teratocarcinoma	14.3%
72	Angiofibroma	14.3%
73	Sarcoma	14.3%
74	Epithelioma	14.3%
75	Composite Lymphoma	14.2%
76	Multiple Endocrine Neoplasia	14.1%
77	Lymphoma	14.1%
78	Leukemia, Myelomonocytic, Chronic	13.8%
79	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	13.8%
80	Carcinoid Tumor	13.5%
81	Neurilemmoma	13.5%
82	Hutchinson's Melanotic Freckle	13.5%
83	Melanoma, Amelanotic	13.5%
84	Liver Neoplasms, Experimental	13.3%
85	Neoplasms, Radiation-Induced	13.2%
86	Acanthoma	13.1%
87	Cystadenocarcinoma	13%
88	Fibrosarcoma	13%
89	Osteosarcoma	13%
90	Mucoepidermoid Carcinoma	13%
91	Choriocarcinoma	12.5%
92	Carcinoma, Lobular	12.5%
93	Abdominal Neoplasms	12.4%
94	Erythroplasia	12.4%
95	Follicular cyst	12.4%
96	Head and Neck Neoplasms	12.4%
97	Mucocele	12.4%
98	Pilonidal Cyst	12.4%
99	Soft Tissue Neoplasms	12.4%
100	Thoracic Neoplasms	12.4%
101	Thyroglossal Cyst	12.4%
102	Synovial Cyst	12.4%
103	Aberrant Crypt Foci	12.4%
104	Paraneoplastic Encephalomyelitis	12.2%
105	Astrocytoma	12.2%
106	Ependymoma	12.2%
107	oligodendroglioma	12.2%
108	Ganglioglioma	12.2%
109	gliosarcoma	12.2%
110	Anaplastic astrocytoma	12.2%
111	Anaplastic Oligodendroglioma	12.2%
112	Adenofibroma	12.1%
113	Fibroadenoma	12.1%
114	Malignant Fibrous Histiocytoma	12.1%
115	Thymoma	11.8%
116	Malignant Carcinoid Syndrome	11.5%
117	Bowen's Disease	11.3%
118	Paraganglioma	11.3%
119	Rhabdomyosarcoma	11.3%
120	Giant Cell Tumor of Bone	11.3%
121	Leukemia, T-Cell	11%
122	Leukemia, B-Cell	11%
123	Glioblastoma	10.9%
124	Neuroblastoma	10.9%
125	Glioblastoma Multiforme	10.9%
126	Plasmacytoma	10.7%
127	Endometrial Stromal Sarcoma	10.7%
128	Malignant histiocytosis	10.7%
129	Histiocytic sarcoma	10.7%
130	Leukemia, Myeloid, Chronic-Phase	10.5%
131	Dermatofibrosarcoma	10.5%
132	Dermatofibrosarcoma Protuberans	10.5%
133	Retinoblastoma	10.2%
134	Ganglioneuroblastoma	10.2%
135	Tuberous Sclerosis	10.1%
136	Adenocarcinoma	9.8%
137	Carcinoma in Situ	9.8%
138	Carcinoma, Transitional Cell	9.8%
139	Phyllodes Tumor	9.8%
140	Dysgerminoma	9.8%
141	Hemangioendothelioma	9.8%
142	Lipoma	9.8%
143	Lymphomatoid Granulomatosis	9.8%
144	Myoma	9.8%
145	Myxoma	9.8%
146	Neuroma	9.8%
147	Papilloma	9.8%
148	Pseudomyxoma Peritonei	9.8%
149	Seminoma	9.8%
150	Papillomatosis	9.8%
151	Angiolipoma	9.8%
152	Myelolipoma	9.8%
153	Neoplasms, Bone Tissue	9.8%
154	Neoplasms, Fibrous Tissue	9.8%
155	Smooth Muscle Tumor	9.8%
156	Adenomatosis, Pulmonary	9.8%
157	Adenomatous Polyps	9.8%
158	Carcinoma, Large Cell	9.8%
159	Carcinoma, Small Cell	9.8%
160	Desmoplastic Small Round Cell Tumor	9.8%
161	Chondroma	9.8%
162	Enchondroma	9.8%
163	Digestive System Neoplasms	9.7%
164	Endocrine Gland Neoplasms	9.7%
165	Eye Neoplasms	9.7%
166	Nervous System Neoplasms	9.7%
167	Lymphangioleiomyomatosis	9.7%
168	Pheochromocytoma	9.6%
169	Alveolar rhabdomyosarcoma	9.6%
170	Bone neoplasms	9.4%
171	Leukoplakia	9.4%
172	Lymphocele	9.4%
173	Pancreatic Cyst	9.4%
174	Skin Neoplasms	9.4%
175	Hematologic Neoplasms	9.4%
176	Barrett Esophagus	9.2%
177	Breast Cyst	9.2%
178	Actinic keratosis	9.2%
179	Mediastinal Cyst	9.2%
180	Neoplasm Invasiveness	9.2%
181	Neoplasm Metastasis	9.2%
182	Neoplasm Recurrence, Local	9.2%
183	Parovarian Cyst	9.2%
184	Pericardial Cyst	9.2%
185	Splenic Neoplasms	9.2%
186	Thymic Cyst	9.2%
187	Carcinogenesis	9.2%
188	Myxoid cyst	9.2%
189	Metastasis	9.2%
190	Nephroblastoma	9.2%
191	Neurofibrosarcoma	9.1%
192	Carcinoid Heart Disease	8.9%
193	Multiple Endocrine Neoplasia Type 1	8.9%
194	Basal Cell Nevus Syndrome	8.6%
195	Hodgkin Disease	8.5%
196	Lymphoma, Non-Hodgkin	8.5%
197	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	8.4%
198	Leukemia, Large Granular Lymphocytic	8.4%
199	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	8.4%
200	Carcinoma, Pancreatic Ductal	8.3%
201	Acoustic Neuroma	8%
202	Parathyroid Neoplasms	7.9%
203	Peritoneal Neoplasms	7.9%
204	Thyroid Neoplasm	7.9%
205	Thyroid carcinoma	7.9%
206	Neoplasms, Experimental	7.8%
207	Hydatidiform Mole	7.7%
208	Retroperitoneal Neoplasms	7.7%
209	Hepatocellular Adenoma	7.7%
210	Adenoid Cystic Carcinoma	7.6%
211	fibroma	7.6%
212	Fibromatosis	7.6%
213	Osteoblastoma	7.6%
214	Osteoma	7.6%
215	Rhabdomyoma	7.6%
216	Chondromatosis	7.6%
217	Adenocarcinoma, Clear Cell	7.6%
218	Cholangiocarcinoma	7.6%
219	Cervical Intraepithelial Neoplasia	7.6%
220	Hemangioblastoma	7.6%
221	Lymphoma, Extranodal NK-T-Cell	7.6%
222	Corpus Luteum Cyst	7.3%
223	Ovarian Cysts	7.3%
224	Primary amyloidosis	7.1%
225	Vipoma	7.1%
226	Optic Nerve Glioma	7.1%
227	Mesoblastic Nephroma	6.9%
228	Pancreatic Neoplasm	6.8%
229	leukemia	6.7%
230	Tracheal Neoplasms	6.7%
231	Leukoplakia, Oral	6.6%
232	Paraneoplastic Cerebellar Degeneration	6.6%
233	Prolactinoma	6.5%
234	Growth Hormone-Secreting Pituitary Adenoma	6.5%
235	Fibromatosis, Aggressive	6.5%
236	Fibromatosis, Abdominal	6.5%
237	Klatskin Tumor	6.5%
238	Adenomatous Polyposis Coli	6.3%
239	Choledochal Cyst	6.2%
240	Peutz-Jeghers Syndrome	6.1%
241	insulinoma	6%
242	Leukemia, Experimental	6%
243	Mastocytosis	6%
244	Sturge-Weber Syndrome	6%
245	Gastrointestinal Stromal Tumors	5.9%
246	Hemangioma, Cavernous	5.9%
247	Mouth Neoplasms	5.9%
248	Central Nervous System Neoplasms	5.9%
249	Vascular Neoplasms	5.9%
250	Thymus Neoplasms	5.9%
251	neurofibroma	5.8%
252	Lymphoma, Follicular	5.8%
253	T-Cell Lymphoma	5.8%
254	Mantle cell lymphoma	5.8%
255	Genital Neoplasms, Female	5.8%
256	Pancreatic Pseudocyst	5.8%
257	Lymphatic Metastasis	5.7%
258	Neoplasms, Unknown Primary	5.7%
259	Leukemic Infiltration	5.7%
260	Breast Neoplasms, Male	5.7%
261	Neoplasm Micrometastasis	5.7%
262	Triple Negative Breast Neoplasms	5.7%
263	Mastocytoma	5.7%
264	Mastocytosis, Systemic	5.7%
265	granulosa cell tumor	5.7%
266	Carcinoma, Ovarian Epithelial	5.7%
267	Esophageal Neoplasms	5.7%
268	Gastrinoma	5.6%
269	Glucagonoma	5.6%
270	Limbic Encephalitis	5.6%
271	Thyroid Nodule	5.5%
272	Waldenstrom Macroglobulinemia	5.3%
273	Multiple Myeloma	5.3%
274	Leydig Cell Tumor	5.2%
275	Adrenocortical carcinoma	5.1%
276	Lambert-Eaton Myasthenic Syndrome	5%
277	Testicular Neoplasms	5%
278	Leukemia P388	4.9%
279	Adrenal Gland Neoplasms	4.8%
280	Gastrointestinal Neoplasms	4.8%
281	Genital Neoplasms, Male	4.8%
282	Liver neoplasms	4.8%
283	Uveal Neoplasms	4.8%
284	Urologic Neoplasms	4.7%
285	Sebaceous Gland Neoplasms	4.6%
286	Spinal Neoplasms	4.6%
287	Bone Marrow Neoplasms	4.6%
288	Polycystic Ovary Syndrome	4.6%
289	Lymphoma, T-Cell, Cutaneous	4.5%
290	Lymphoma, AIDS-Related	4.5%
291	Enteropathy-Associated T-Cell Lymphoma	4.5%
292	Primary Effusion Lymphoma	4.5%
293	Nasopharyngeal carcinoma	4.5%
294	Denys-Drash Syndrome	4.5%
295	Opsoclonus-Myoclonus Syndrome	4.4%
296	Renal Cell Carcinoma	4.4%
297	Papillary Renal Cell Carcinoma	4.4%
298	Carcinoma, Endometrioid	4.2%
299	Meningeal Neoplasms	4.1%
300	Dupuytren Contracture	4%
301	Myelitis, Transverse	3.9%
302	Urticaria Pigmentosa	3.9%
303	Mycosis Fungoides	3.8%
304	Lymphomatoid Papulosis	3.8%
305	Plasmablastic lymphoma	3.8%
306	Nose Neoplasms	3.8%
307	Xeroderma Pigmentosum	3.7%
308	Palatal Neoplasms	3.7%
309	Ear Neoplasms	3.4%
310	Eyelid Neoplasms	3.4%
311	Lung Neoplasms	3.4%
312	Pleural Neoplasms	3.4%
313	Pituitary Adenoma	3.4%
314	Pituitary Neoplasms	3.4%
315	ovarian neoplasm	3.3%
316	Cell Transformation, Viral	3.3%
317	Brain Neoplasms	3.3%
318	Salivary Gland Neoplasms	3.3%
319	Spinal Cord Neoplasms	3.3%
320	Tongue Neoplasms	3.3%
321	Uterine Neoplasms	3.2%
322	Vaginal Neoplasms	3.2%
323	Vulvar Neoplasms	3.2%
324	Uterine Cancer	3.2%
325	Meningeal Carcinomatosis	3.2%
326	Fallopian Tube Neoplasms	3.2%
327	Burkitt Lymphoma	3.2%
328	Pharyngeal Neoplasms	2.8%
329	Central Nervous System Cysts	2.8%
330	Sezary Syndrome	2.8%
331	Bile Duct Neoplasms	2.7%
332	gallbladder neoplasm	2.7%
333	Intestinal Neoplasms	2.7%
334	Penile Neoplasms	2.7%
335	Prostatic Neoplasms	2.7%
336	Stomach Neoplasms	2.7%
337	Polycythemia Vera	2.7%
338	Bronchial Neoplasms	2.7%
339	Multiple Pulmonary Nodules	2.6%
340	Supratentorial Neoplasms	2.6%
341	Endometrial Neoplasms	2.6%
342	Zollinger-Ellison syndrome	2.6%
343	Laryngeal neoplasm	2.5%
344	Bladder Neoplasm	2.3%
345	Kidney Neoplasm	2.3%
346	Ureteral Neoplasms	2.3%
347	Urethral Neoplasms	2.3%
348	Brain Stem Neoplasms	2.2%
349	Hypopharyngeal Neoplasms	2.2%
350	Pleural Effusion, Malignant	2.2%
351	Hypopharyngeal Cancer	2.2%
352	Parotid Neoplasms	2.2%
353	Prostatic Neoplasms, Castration-Resistant	2.2%
354	Nelson Syndrome	2.1%
355	Choroid Plexus Papilloma	2.1%
356	Tonsillar Neoplasms	1.9%
357	Cerebellar Neoplasms	1.9%
358	Cecal Neoplasms	1.8%
359	Duodenal Neoplasms	1.8%
360	Nasopharyngeal Neoplasms	1.6%
361	Colorectal Neoplasms	1.6%
362	Radicular Cyst	1.6%
363	Appendiceal Neoplasms	1.6%
364	Colonic Neoplasms	1.6%
365	Rectal Neoplasms	1.6%
366	Paranasal Sinus Neoplasms	1.5%
367	Anus Neoplasms	1.3%
368	Sigmoid Neoplasms	1.3%
369	Maxillary Sinus Neoplasms	1.3%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262